Copyright
©The Author(s) 2015.
World J Diabetes. Sep 10, 2015; 6(11): 1179-1185
Published online Sep 10, 2015. doi: 10.4239/wjd.v6.i11.1179
Published online Sep 10, 2015. doi: 10.4239/wjd.v6.i11.1179
Level | In vitro parameters | In vivo parameters | Utility |
Level A: direct relationship with in vivo data based on in vitro measurement alone | Dissolution curves | Absorption curves | Highest level of correlation depicting point to point relation between in vitro dissolution rate and in vivo input rate of drug from dosage form. Marks in vitro dissolution as the surrogate of in vivo performance |
Level B: relation based on statistical moments analysis | MDT | MAT; MRT | Mean in vitro dissolution time of the product compared to mean in vivo residence time or mean in vivo dissolution time |
Level C: relates one dissolution time point (t50%, t90%, etc.) to one mean pharmacokinetic parameter (AUC, Cmax, tmax) | Disintegration time, time to have 10%, 50%, 90% dissolved, dissolution rate, dissolution efficiency | Cmax, Tmax, Ka, time to have 10%, 50%, 90% absorbed, AUC (total or cumulative) | Single point weak correlation showing a partial relation between absorption and dissolution. Used in early stages of formulation development before pilot production |
- Citation: De B, Bhandari K, Chakravorty N, Mukherjee R, Gundamaraju R, Singla RK, Katakam P, Adiki SK, Ghosh B, Mitra A. Computational pharmacokinetics and in vitro-in vivo correlation of anti-diabetic synergistic phyto-composite blend. World J Diabetes 2015; 6(11): 1179-1185
- URL: https://www.wjgnet.com/1948-9358/full/v6/i11/1179.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i11.1179